How OREF’s Orizon fund and incubator protects the surgeon researcher first.

2 Mar 2025 · 1 min
1:09

OREF's Orizon fund protects surgeon-researchers by guaranteeing them a fixed percentage of equity at sale, documented in writing. Most inventors lose their stake through multiple funding rounds, so Orizon locks in ownership upfront to keep innovators from getting diluted out.

Chapters

More from Tiger

1:00:35
youtube.com

BoneChat #146 - Raising Capital, Protecting Equity, Dilution & Staying Lean

1w ago
58:35
youtube.com

BoneChat #145 - ASC Robots, Direct-to-Patient Marketing & Ortho Startup Reality

2w ago
57:20
youtube.com

BoneChat #144 - Defining the Standard of Care for Orthopedic Tissue Preservation & Restoration

4w ago
56:40
youtube.com

BoneChat #143 - AI-Driven MedTech Sales, Startup Traps, & Orthopedic Commercialization

1mo ago
1:20
youtube.com

Reverse Shoulder movement in the US

1mo ago
1:03:29
youtube.com

BoneChat #142 - Fastest-Growing Ortho Segments, Reverse Shoulder & Joint Preservation Rollups

1mo ago
59:10
youtube.com

BoneChat #141 - Disrupting Surgical Visualization: Single-Use 4K Scopes with Richard McKillop

1mo ago
57:56
youtube.com

BoneChat #140 - Transforming Knee Rehab, Patient Experience, and MedTech Go-to-Market

1mo ago
0:36
youtube.com

How to find early adopters in Ortho.

2mo ago
0:35
youtube.com

The Importance of Controlling Your Own Destiny in Deals

2mo ago
0:50
youtube.com

Red Flags in Business Partnerships

2mo ago
See all content